Literature DB >> 17065066

Familial juvenile hyperuricaemic nephropathy is not such a rare genetic metabolic purine disease in Britain.

H A Simmonds1, J S Cameron, D J Goldsmith, L D Fairbanks, G Venkat Raman.   

Abstract

Renal disease is rare today in classic adult gout, and gout is rare in renal disease--especially in the young. Here we summarise studies in 158 patients from 31 kindreds diagnosed with familial juvenile hyperuricaemic nephropathy FJHN from a total of 230 kindred members studied in Great Britain. Some patients have been followed for up to 30 years, and allopurinol has ameliorated the progression of the renal disease in all 113 surviving members provided: They have been diagnosed and treated sufficiently early. Compliance with allopurinol treatment and diet has been as important as early recognition. Hypertension has been rigorously controlled. The use of oral contraceptives has been avoided, as has pregnancy in any female with a Glomelar Filtration Rate GFR <70 ml/min. The question arising is: Why is FJHN the most prevalent genetic purine disorder diagnosed in Britain? Is it a lack of awareness which needs to be improved Europe-wide?

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17065066     DOI: 10.1080/15257770600891028

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  5 in total

1.  Characterization of a recurrent in-frame UMOD indel mutation causing late-onset autosomal dominant end-stage renal failure.

Authors:  Graham D Smith; Caroline Robinson; Andrew P Stewart; Emily L Edwards; Hannah I Karet; Anthony G W Norden; Richard N Sandford; Fiona E Karet Frankl
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 8.237

2.  Genome-wide study of familial juvenile hyperuricaemic (gouty) nephropathy (FJHN) indicates a new locus, FJHN3, linked to chromosome 2p22.1-p21.

Authors:  Sian E Piret; Patrick Danoy; Karin Dahan; Anita A C Reed; Karena Pryce; William Wong; Rosa J Torres; Juan G Puig; Thomas Müller; Peter Kotanko; Karl Lhotta; Olivier Devuyst; Matthew A Brown; Rajesh V Thakker
Journal:  Hum Genet       Date:  2010-10-26       Impact factor: 4.132

3.  Epidemiology of uromodulin-associated kidney disease - results from a nation-wide survey.

Authors:  Karl Lhotta; Sian E Piret; Reinhard Kramar; Rajesh V Thakker; Gere Sunder-Plassmann; Peter Kotanko
Journal:  Nephron Extra       Date:  2012-06-01

Review 4.  Managing Gout in Women: Current Perspectives.

Authors:  Aakash V Patel; Angelo L Gaffo
Journal:  J Inflamm Res       Date:  2022-03-03

5.  Whole genome sequence analysis identifies a PAX2 mutation to establish a correct diagnosis for a syndromic form of hyperuricemia.

Authors:  Mark Stevenson; Alistair T Pagnamenta; Silvia Reichart; Charlotte Philpott; Kate E Lines; Caroline M Gorvin; Karl Lhotta; Jenny C Taylor; Rajesh V Thakker
Journal:  Am J Med Genet A       Date:  2020-08-09       Impact factor: 2.578

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.